KOD
Price
$22.96
Change
+$0.96 (+4.36%)
Updated
Dec 3 closing price
Capitalization
1.21B
112 days until earnings call
Intraday BUY SELL Signals
QNCX
Price
$3.52
Change
+$0.14 (+4.14%)
Updated
Dec 3 closing price
Capitalization
196M
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KOD vs QNCX

Header iconKOD vs QNCX Comparison
Open Charts KOD vs QNCXBanner chart's image
Kodiak Sciences
Price$22.96
Change+$0.96 (+4.36%)
Volume$686.04K
Capitalization1.21B
Quince Therapeutics
Price$3.52
Change+$0.14 (+4.14%)
Volume$1.12M
Capitalization196M
KOD vs QNCX Comparison Chart in %
KOD
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KOD vs. QNCX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Buy and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (KOD: $22.01 vs. QNCX: $3.39)
Brand notoriety: KOD and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 38% vs. QNCX: 124%
Market capitalization -- KOD: $1.21B vs. QNCX: $196M
KOD [@Biotechnology] is valued at $1.21B. QNCX’s [@Biotechnology] market capitalization is $196M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 0 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 0 green, 5 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, both KOD and QNCX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 4 TA indicator(s) are bullish while QNCX’s TA Score has 5 bullish TA indicator(s).

  • KOD’s TA Score: 4 bullish, 4 bearish.
  • QNCX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both KOD and QNCX are a good buy in the short-term.

Price Growth

KOD (@Biotechnology) experienced а -4.26% price change this week, while QNCX (@Biotechnology) price change was +26.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

KOD is expected to report earnings on Mar 26, 2026.

QNCX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($1.22B) has a higher market cap than QNCX($196M). KOD YTD gains are higher at: 121.206 vs. QNCX (81.283). QNCX has higher annual earnings (EBITDA): -41.32M vs. KOD (-170.11M). KOD has more cash in the bank: 104M vs. QNCX (34.7M). QNCX has less debt than KOD: QNCX (17.5M) vs KOD (65.2M). KOD (0) and QNCX (0) have equivalent revenues.
KODQNCXKOD / QNCX
Capitalization1.22B196M620%
EBITDA-170.11M-41.32M412%
Gain YTD121.20681.283149%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M34.7M300%
Total Debt65.2M17.5M373%
FUNDAMENTALS RATINGS
KOD vs QNCX: Fundamental Ratings
KOD
QNCX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (80) in the Biotechnology industry is in the same range as QNCX (93). This means that KOD’s stock grew similarly to QNCX’s over the last 12 months.

KOD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that KOD’s stock grew similarly to QNCX’s over the last 12 months.

KOD's SMR Rating (99) in the Biotechnology industry is in the same range as QNCX (99). This means that KOD’s stock grew similarly to QNCX’s over the last 12 months.

KOD's Price Growth Rating (34) in the Biotechnology industry is in the same range as QNCX (34). This means that KOD’s stock grew similarly to QNCX’s over the last 12 months.

KOD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that KOD’s stock grew similarly to QNCX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODQNCX
RSI
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
84%
Momentum
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
90%
MACD
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 7 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 7 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 29 days ago
88%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
81%
Aroon
ODDS (%)
Bullish Trend 7 days ago
90%
Bearish Trend 7 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIABF0.16N/A
N/A
CAPITAL A BERHAD
ESYJY6.50N/A
N/A
easyJet Plc
NHOLF29.81N/A
N/A
Sompo Hldgs Inc
NZERF0.14N/A
N/A
New Zealand Energy Corp.
BCBNF0.80N/A
N/A
Base Carbon Inc.

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with MBX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then MBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+0.32%
MBX - KOD
46%
Loosely correlated
+0.64%
MGNX - KOD
45%
Loosely correlated
-2.06%
MRNA - KOD
44%
Loosely correlated
-0.41%
CRBU - KOD
43%
Loosely correlated
-0.56%
IDYA - KOD
43%
Loosely correlated
-1.75%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+6.94%
MNPR - QNCX
35%
Loosely correlated
-8.67%
ADCT - QNCX
31%
Poorly correlated
+8.61%
CLNN - QNCX
29%
Poorly correlated
-2.09%
KOD - QNCX
28%
Poorly correlated
+0.32%
MDXG - QNCX
27%
Poorly correlated
+0.67%
More